AIM: The present study aimed to investigate the role of Interleukin 15 (IL-15) in protein degradation in skeletal muscle mediated by the ubiquitin-proteasome pathway (UPP) in a rat model of chronic obstructive pulmonary disease (COPD). METHODS: The COPD model was established in 30 Sprague Dawley (SD) rats through the combination of passive smoking and intratracheal injection of lipopolysaccharide (LPS). The pathological changes in lungs and bronchi of COPD rats (n=30) were compared with that of control rats (n=15). The levels of IL-15 and tumor necrosis factor-α (TNF- α) in the serum, diaphragm, gastrocnemius, and the intercostal muscles were measured using enzyme-linked immunosorbent assay (ELISA), and compared between the COPD and control rats. In addition, the expression of E2-14K, MAFbx, and ubiquitin (Ub) was evaluated using quantitative real-time PCR and western blot and compared between the COPD and control rats. RESULTS: The levels of IL-15 and TNF-α in the serum, diaphragm, gastrocnemius, and the intercostal muscles in COPD rats were significantly higher than that in control rats. The expression of E2-14K, MAFbx, and ubiquitin (Ub) in the diaphragm, gastrocnemius, and the intercostal muscles in COPD rats was also significantly higher than that in the control rats. In addition, we identified positive correlation between the levels of IL-15 and TNF-α. Positive correlation was also identified between the levels of IL-15 and E2-14K, MAFbx, and Ub. CONCLUSION: Our results suggest that IL-15 inhibited the protein degradation in skeletal muscle in COPD rats, which may be mediated by the TNF-α and UPP pathway.
AIM: The present study aimed to investigate the role of Interleukin 15 (IL-15) in protein degradation in skeletal muscle mediated by the ubiquitin-proteasome pathway (UPP) in a rat model of chronic obstructive pulmonary disease (COPD). METHODS: The COPD model was established in 30 Sprague Dawley (SD) rats through the combination of passive smoking and intratracheal injection of lipopolysaccharide (LPS). The pathological changes in lungs and bronchi of COPD rats (n=30) were compared with that of control rats (n=15). The levels of IL-15 and tumor necrosis factor-α (TNF- α) in the serum, diaphragm, gastrocnemius, and the intercostal muscles were measured using enzyme-linked immunosorbent assay (ELISA), and compared between the COPD and control rats. In addition, the expression of E2-14K, MAFbx, and ubiquitin (Ub) was evaluated using quantitative real-time PCR and western blot and compared between the COPD and control rats. RESULTS: The levels of IL-15 and TNF-α in the serum, diaphragm, gastrocnemius, and the intercostal muscles in COPD rats were significantly higher than that in control rats. The expression of E2-14K, MAFbx, and ubiquitin (Ub) in the diaphragm, gastrocnemius, and the intercostal muscles in COPD rats was also significantly higher than that in the control rats. In addition, we identified positive correlation between the levels of IL-15 and TNF-α. Positive correlation was also identified between the levels of IL-15 and E2-14K, MAFbx, and Ub. CONCLUSION: Our results suggest that IL-15 inhibited the protein degradation in skeletal muscle in COPD rats, which may be mediated by the TNF-α and UPP pathway.
Authors: Coen A C Ottenheijm; Leo M A Heunks; Yi-Ping Li; Bingwen Jin; Ronnie Minnaard; Hieronymus W H van Hees; P N Richard Dekhuijzen Journal: Am J Respir Crit Care Med Date: 2006-08-17 Impact factor: 21.405
Authors: C García-Martínez; M Llovera; N Agell; F J López-Soriano; J M Argilés Journal: Biochem Biophys Res Commun Date: 1994-06-15 Impact factor: 3.575
Authors: LeBris S Quinn; Barbara G Anderson; Rolf H Drivdahl; Belén Alvarez; Josep M Argilés Journal: Exp Cell Res Date: 2002-10-15 Impact factor: 3.905
Authors: Yi-Ping Li; Yuling Chen; Joseph John; Jennifer Moylan; Bingwen Jin; Douglas L Mann; Michael B Reid Journal: FASEB J Date: 2005-03 Impact factor: 5.191
Authors: Mariève Doucet; Aaron P Russell; Bertrand Léger; Richard Debigaré; Denis R Joanisse; Marc-André Caron; Pierre LeBlanc; François Maltais Journal: Am J Respir Crit Care Med Date: 2007-05-03 Impact factor: 21.405
Authors: K H Grabstein; J Eisenman; K Shanebeck; C Rauch; S Srinivasan; V Fung; C Beers; J Richardson; M A Schoenborn; M Ahdieh Journal: Science Date: 1994-05-13 Impact factor: 47.728
Authors: N Carbó; J López-Soriano; P Costelli; S Busquets; B Alvarez; F M Baccino; L S Quinn; F J López-Soriano; J M Argilés Journal: Br J Cancer Date: 2000-08 Impact factor: 7.640
Authors: Anthony P Brown; Lucy Cai; Benjamin I Laufer; Lisa A Miller; Janine M LaSalle; Hong Ji Journal: Environ Int Date: 2021-11-24 Impact factor: 9.621